Gastro Inflammation Research Formula (BPC-157 + KPV + N-Acetyl Larazotide) - A multi-compound research blend designed for laboratories studying how multiple GI signaling pathways interact within the same model
It can also be combined with BPC-157 in the same syringe for convenience, though they should be reconstituted in separate vials
Typical use involves 200-400 mcg total per injection (100-200 mcg of each peptide), with frequency ranging from once to three times daily depending on research goals
Rheumatology (Oxford) 2009;48(7):716720
This low-grade systemic inflammation: Impairs insulin receptor signalling, directly worsening insulin resistance Damages ovarian granulosa cells, impairing egg development and ovarian function Disrupts gut barrier integrity, contributing to what some researchers call a "leaky gut" pattern associated with systemic inflammation Amplifies HPA axis dysregulation, raising cortisol and further disrupting sex hormone balance Chronic inflammation is both a consequence of PMOS and a driver that perpetuates it
It protects cells from oxidative stress and supports mitochondrial function
